GE Healthcare‘s quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis of heart disease can help the Club stock make some more noise.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts


This will close in 0 seconds